Market Overview

Chardan: R1 RCM Will Make A Full Recovery

88 Biggest Movers From Yesterday
54 Biggest Movers From Yesterday

Even as it reflects on 56-percent year-over-year gains, R1 RCM Inc (NASDAQ: RCM) has struck an “attractive inflection point,” according to Chardan Capital Markets.

The Rating

Analyst Steven Wardell initiated coverage on R1 RCM with a Buy rating and a $17 price target.

The Thesis

Chardan expects superior top-line growth in RCM relative to peers, particularly given the firm’s high recurring revenue rate and recent expansion beyond its core Ascension business.

“We like the company’s ability to boost hospital economics in ways that are strong compared to revenue cycle competitors,” Wardell wrote in a Tuesday note.

He regards RCM as a leading revenue-cycle-management vendor in the U.S. hospital market and expects continued growth as macro trends favor increased software and service outsourcing. Chardan’s channel checks indicate a shift in hospital budgets toward revenue-cycle-management services previously done in-house.

In these circumstances, Wardell sees a $100 billion market with 12-percent growth.

“The Street sees R1 RCM as a fallen angel in the middle of a turnaround,” Wardell wrote. “We look positively on the turnaround and see the opportunity for multiple expansion in the stock in the next 12 months.”

Price Action

At time of publication, R1 RCM shares were up 4.5 percent at $10.43.

Related Links:

LifePoint Confirms Sale To Apollo's RCCH, But Analysts Aren't Too Enthusiastic

Morgan Stanley: Veeva Systems' Share Price Fails To Reflect Growth, Margin Potential

Latest Ratings for RCM

Dec 2018CitigroupInitiates Coverage OnBuy
Sep 2018Chardan CapitalInitiates Coverage OnBuy
Aug 2018Cantor FitzgeraldMaintainsOverweightOverweight

View More Analyst Ratings for RCM
View the Latest Analyst Ratings

Posted-In: Chardan Capital Markets Steven WardellAnalyst Color Price Target Initiation Analyst Ratings


Related Articles (RCM)

View Comments and Join the Discussion!

Latest Ratings

CMAB. Riley FBRDowngrades84.0
View the Latest Analytics Ratings
Don't Miss Out!
Join Our Newsletter
Subscribe to:
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Daily Analyst Rating
A summary of each day’s top rating changes from sell-side analysts on the street.
Fintech Focus
Your weekly roundup of hot topics in the exciting world of fintech.
Thank You
for registering for Benzinga’s newsletters and alerts.
• The Daily Analysts Ratings email will be received daily between 7am and 10am.
• The Market in 5 Minutes email will be received daily between 7am and 8am.
• The Fintech Focus email will be received every Friday between 2pm and 5pm.

Survey: Women More Likely To Miss A Credit Card Payment

Lockheed Martin Wins $250M Deal For F-35 Lightning Program